GlassScriptPhysician profile
Wade B Welch
NPI 1518962851
$2,727.21
in general payments reported to CMS, 2019-2025
37 companies · $35.45 in 2025
The $35.45 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,929 · 2020: $296 · 2021: $19.54 · 2022: $37.85 · 2023: $192 · 2024: $218 · 2025: $35.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $333.04 | 2019-2024 | Nayzilam, Briviact |
| Biogen, INC. | $260.73 | 2019-2023 | Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $186.99 | 2019 | |
| Allergan, INC. | $181.31 | 2019-2020 | |
| Abbvie INC. | $171.40 | 2019-2023 | Botox, Ubrelvy, Qulipta |
| Genzyme Corporation | $147.90 | 2019-2020 | |
| Amgen INC. | $145.76 | 2019-2020 | |
| Pfizer INC. | $119.21 | 2019-2025 | |
| Genentech USA, INC. | $118.09 | 2019-2025 | Ocrevus Zunovo |
| Avanir Pharmaceuticals, INC. | $112.34 | 2019 | |
| Acadia Pharmaceuticals INC | $93.57 | 2019-2020 | |
| Acorda Therapeutics, INC | $92.36 | 2019 | |
| Emd Serono, INC. | $87.11 | 2019-2020 | |
| Zyla Life Sciences, INC. | $66.13 | 2019 | |
| Lilly USA, LLC | $58.34 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $54.71 | 2019 | |
| Corium, LLC | $42.37 | 2022-2023 | Adlarity |
| Medtronic, INC. | $38.88 | 2024 | Percept PC Brainsense |
| Amneal Pharmaceuticals LLC | $38.86 | 2019 | |
| Scilex Pharmaceuticals INC. | $35.21 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $27.32 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $25.90 | 2019 | |
| Sunovion Pharmaceuticals INC. | $25.50 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.50 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.93 | 2019 | |
| Tanabe Pharma America, INC. | $23.84 | 2019 | |
| Jazz Pharmaceuticals INC. | $21.91 | 2019 | |
| Livanova USA, INC. | $21.18 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.03 | 2019 | |
| Saol Therapeutics INC. | $19.02 | 2019 | |
| Adamas Pharmaceuticals, INC. | $17.86 | 2020 | |
| Neurocrine Biosciences, INC. | $17.81 | 2019 | |
| Grt US Holding, INC. | $16.52 | 2020 | |
| Promius Pharma LLC | $15.70 | 2019 | |
| Boston Scientific Corporation | $15.34 | 2019 | |
| Celgene Corporation | $13.98 | 2022 | |
| Supernus Pharmaceuticals, INC. | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.